UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000013171
Receipt number R000015359
Scientific Title Prospective observational study of hospitalization associated disability in the elderly patients living with advanced non-small cell lung cancer.
Date of disclosure of the study information 2014/02/17
Last modified on 2023/02/25 10:02:58

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prospective observational study of hospitalization associated disability in the elderly patients living with advanced non-small cell lung cancer.

Acronym

Hospitalization associated disability in elderly patients with NSCLC

Scientific Title

Prospective observational study of hospitalization associated disability in the elderly patients living with advanced non-small cell lung cancer.

Scientific Title:Acronym

Hospitalization associated disability in elderly patients with NSCLC

Region

Japan


Condition

Condition

non-small cell lung cancer

Classification by specialty

Pneumology Hematology and clinical oncology Rehabilitation medicine
Nursing

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To elucidate the risk-factors of hospitalization associated disability (HAD) in the elderly NSCLC patients receiving chemotherapy.

Basic objectives2

Others

Basic objectives -Others

To elucidate the association between HAD and changes in physical activity, lifestyle, and QOL.

Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Changes in Barthel Index in each period of hospitalization.

Key secondary outcomes

Changes in lifestyle, physical activity, health related QOL, and Barthel Index during the follow-up period.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

70 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) >=70 years old
2) Non-small cell lung cancer in stage IV or post-operative relapse.
3) They planned to receive the chemotherapy.
4) ECOG-PS 0-2
5) Having written informed consent
6) They can be done physical assessment safely.
7) More than 12 weeks of survival was expected.

Key exclusion criteria

Those who have the risks for physical assessments including heart, bone, neurological, or psychological diseases.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Tateaki
Middle name
Last name Tateaki Naito

Organization

Shizuoka Cancer Center

Division name

Division of Thoracic Oncology

Zip code

411-8777

Address

1007 Shimnagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, Japan

TEL

0559895222

Email

t.naito@scchr.jp


Public contact

Name of contact person

1st name Tateaki
Middle name
Last name Naito

Organization

Shizuoka Cancer Center

Division name

Division of Thoracic Oncology

Zip code

411-8777

Address

1007 Shimnagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, Japan

TEL

+81-55-989-5222

Homepage URL


Email

t.naito@scchr.jp


Sponsor or person

Institute

Shizuoka Cancer Center

Institute

Department

Personal name



Funding Source

Organization

Shizuoka Cancer Center

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shizuoka Cancer Center

Address

1007 Shimonagakubo, Nagaizumi, Sunto, Shizuoka

Tel

0559895222

Email

t.naito@scchr.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

静岡県立静岡がんセンター


Other administrative information

Date of disclosure of the study information

2014 Year 02 Month 17 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications

http://www.apjon.org/preprintarticle.asp?id=233787

Number of participants that the trial has enrolled

33

Results


Results date posted


Results Delayed

Delay expected

Results Delay Reason

under review

Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 02 Month 07 Day

Date of IRB

2014 Year 02 Month 17 Day

Anticipated trial start date

2014 Year 02 Month 17 Day

Last follow-up date

2020 Year 06 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

1. accelerometer (Lifecorder-GS)
2. Barthel Index
3. EORTC-C30 and EQ-5D
4. Lifestyle questionnaire


Management information

Registered date

2014 Year 02 Month 15 Day

Last modified on

2023 Year 02 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015359


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name